Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Cellular communication network factor 2 (CCN2), also known as connective tissue growth factor (CTGF), is a secreted, cysteine-rich matricellular protein comprised of four conserved modular domains (IGFBP, VWC, TSP1, CT) and is primarily involved in extracellular matrix signaling and remodeling[1][2][4]. Unlike classical growth factors, CCN2 acts as a regulatory hub by binding a variety of cell surface receptors (including integrins and LRPs) and growth factors (such as TGF-β and VEGF), thereby modulating key biological processes like cell proliferation, differentiation, angiogenesis, fibrosis, and tissue repair[1][2][4]. CCN2 is implicated in various pathological conditions, including cancer, fibrosis, and inflammatory diseases, and is being investigated as a therapeutic target and clinical biomarker, though its complex and context-dependent roles warrant careful consideration in drug development and disease monitoring[1][2][4].
Modulation of interaction with cell surface receptors and growth factors Inhibition of fibrogenic signaling Regulation of immune cell differentiation (e.g., Th17 differentiation)[3] Interference with extracellular matrix remodeling
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Cellular communication network factor 2 (CCN2).